(Reuters Health) - Getting a head start on Pfizer’s anti-smoking drug Chantix may help smokers kick the habit, according to a preliminary study funded by the company. More than a third of smokers who started on the drug a month before quitting were still completely smoke-free 3 months later. That compared to about one in seven of those who only started Chantix the recommended one week before they quit.
